Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P. R. China; Department of Anesthesiology, West China Second Hospital, Sichuan University, Chengdu 610041, Sichuan, P. R. China.
Department of Anesthesiology, West China Second Hospital, Sichuan University, Chengdu 610041, Sichuan, P. R. China.
J Clin Anesth. 2014 Nov;26(7):557-62. doi: 10.1016/j.jclinane.2014.03.014. Epub 2014 Oct 16.
To determine the dose of succinylcholine during inhalation induction of a patient.
Prospective, double-blind, randomized study.
Operating room of a university hospital.
180 adult, ASA physical status 1 and 2 patients with a suspected difficult airway, who were scheduled for surgery.
Nonpremedicated patients were anesthetized with inhalation of 8% sevoflurane, followed by succinylcholine. Group 1 received intravenous (IV) succinylcholine 0.3 mg/kg, Group 2 had IV succinylcholine 0.6 mg/kg, and Group 3 was given IV succinylcholine 1.0 mg/kg. Direct laryngoscopy and tracheal intubation were performed after onset of succinylcholine.
Intubation conditions were scored as excellent, good, or poor. The recovery time of spontaneous respiration, end-tidal carbon dioxide partial pressure (PETCO2), and pulse oxygen saturation (SpO2) were recorded.
Acceptable conditions (excellent and good) for intubation were rated in 80% of Group 1 patients (0.3 mg/kg succhinylcholine), 91.7% of Group 2 patients (0.6 mg/kg), and 93.3% of Group 3 patients (1.0 mg/kg), respectively. Intubation scores were similar in Groups 2 and 3, and were significantly higher than in Group 1 patients (0.3 mg; P < 0.01). Time to recovery of spontaneous respiration in Group 3 was significantly prolonged compared with Groups 1 and 2 (238 ± 59 sec vs 132 ± 43 sec, P < 0.001; 238 ± 59 sec vs 151 ± 47 sec, P < 0.001, respectively). SpO2 in Group 3 did not differ significantly from Group 1 and 2 values. However, PETCO2 in Group 3 was significantly higher than in Groups 1 or 2.
Succinylcholine at a dose of 0.6 mg/kg IV provided intubation conditions similar to succinylcholine at 1.0 mg/kg IV, and recovery of spontaneous respiration following a 0.6 mg/kg dose of succinylcholine was significantly shorter.
确定吸入诱导患者时琥珀酰胆碱的剂量。
前瞻性、双盲、随机研究。
一所大学医院的手术室。
180 名成人,ASA 身体状况 1 级和 2 级,怀疑有困难气道,拟行手术。
非预麻醉患者吸入 8%七氟醚,随后给予琥珀酰胆碱。第 1 组患者静脉注射(IV)琥珀酰胆碱 0.3mg/kg,第 2 组患者静脉注射琥珀酰胆碱 0.6mg/kg,第 3 组患者静脉注射琥珀酰胆碱 1.0mg/kg。琥珀酰胆碱起效后行直接喉镜检查和气管插管。
插管条件评分优、良或差。记录自主呼吸恢复时间、呼气末二氧化碳分压(PETCO2)和脉搏血氧饱和度(SpO2)。
第 1 组患者(0.3mg/kg 琥珀酰胆碱)插管条件评为优和良的比例为 80%,第 2 组患者(0.6mg/kg)为 91.7%,第 3 组患者(1.0mg/kg)为 93.3%。第 2 组和第 3 组的插管评分相似,显著高于第 1 组患者(0.3mg;P < 0.01)。第 3 组自主呼吸恢复时间明显长于第 1 组和第 2 组(238 ± 59 秒 vs 132 ± 43 秒,P < 0.001;238 ± 59 秒 vs 151 ± 47 秒,P < 0.001)。第 3 组 SpO2 与第 1 组和第 2 组无显著差异。然而,第 3 组 PETCO2 显著高于第 1 组和第 2 组。
静脉注射 0.6mg/kg 琥珀酰胆碱可提供与静脉注射 1.0mg/kg 琥珀酰胆碱相似的插管条件,且 0.6mg/kg 琥珀酰胆碱后自主呼吸恢复时间显著缩短。